Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lie

Showing results (321-330 of 376) with videos related to

Pageof 38
Sort By:
Plos One|December 19, 2014
Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis populationSigrid Næss, Benedicte A Lie, Espen Melum, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 28, 2016
Genetic overlap between multiple sclerosis and several cardiovascular disease risk factorsYunpeng Wang, Steffan D Bos, Hanne F Harbo, et al.
Immunity, Inflammation and Disease|June 25, 2020
Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B studyMohummad A Rahman, Jorunn Brekke, Victoria Arnesen, et al.
Annals of the Rheumatic Diseases|December 11, 2007
The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseasesM C Eike, G B N Nordang, T H Karlsen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 13, 2014
Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct diseaseSigrid Naess, Einar Björnsson, Jarl A Anmarkrud, et al.
Nature Chemical Biology|March 20, 2012
LYP inhibits T-cell activation when dissociated from CSKTorkel Vang, Wallace H Liu, Laurence Delacroix, et al.
Frontiers in Immunology|June 24, 2021
Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish PopulationsLisa E Creary, Sridevi Gangavarapu, Stacy J Caillier, et al.
Journal of Autoimmunity|September 26, 2006
FOXP3 polymorphisms in type 1 diabetes and coeliac diseaseMarit Bjørnvold, Silja S Amundsen, Lars C Stene, et al.
Neurology|December 19, 2009
HLA-DRB1 and month of birth in multiple sclerosisS V Ramagopalan, J Link, J K Byrnes, et al.
Frontiers in Immunology|March 3, 2020
Rheumatoid Arthritis Patients, Both Newly Diagnosed and Methotrexate Treated, Show More DNA Methylation Differences in CD4<sup>+</sup> Memory Than in CD4<sup>+</sup> Naïve T CellsKari Guderud, Line H Sunde, Siri T Flåm, et al.
Pageof 38

Showing results (321-330 of 376) with videos related to

Sort By:
Pageof 38
Plos One|December 19, 2014
Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis populationSigrid Næss, Benedicte A Lie, Espen Melum, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 28, 2016
Genetic overlap between multiple sclerosis and several cardiovascular disease risk factorsYunpeng Wang, Steffan D Bos, Hanne F Harbo, et al.
Immunity, Inflammation and Disease|June 25, 2020
Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B studyMohummad A Rahman, Jorunn Brekke, Victoria Arnesen, et al.
Annals of the Rheumatic Diseases|December 11, 2007
The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseasesM C Eike, G B N Nordang, T H Karlsen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 13, 2014
Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct diseaseSigrid Naess, Einar Björnsson, Jarl A Anmarkrud, et al.
Nature Chemical Biology|March 20, 2012
LYP inhibits T-cell activation when dissociated from CSKTorkel Vang, Wallace H Liu, Laurence Delacroix, et al.
Frontiers in Immunology|June 24, 2021
Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish PopulationsLisa E Creary, Sridevi Gangavarapu, Stacy J Caillier, et al.
Journal of Autoimmunity|September 26, 2006
FOXP3 polymorphisms in type 1 diabetes and coeliac diseaseMarit Bjørnvold, Silja S Amundsen, Lars C Stene, et al.
Neurology|December 19, 2009
HLA-DRB1 and month of birth in multiple sclerosisS V Ramagopalan, J Link, J K Byrnes, et al.
Frontiers in Immunology|March 3, 2020
Rheumatoid Arthritis Patients, Both Newly Diagnosed and Methotrexate Treated, Show More DNA Methylation Differences in CD4<sup>+</sup> Memory Than in CD4<sup>+</sup> Naïve T CellsKari Guderud, Line H Sunde, Siri T Flåm, et al.
Pageof 38